AAAAAA
Results: 1-25/53
Authors:
Ylikoski, A
Karp, M
Pettersson, K
Lilja, H
Lovgren, T
Citation: A. Ylikoski et al., Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patients, J MOL DIAGN, 3(3), 2001, pp. 111-122
Authors:
Tornblom, M
Norming, U
Becker, C
Lilja, H
Gustafsson, O
Citation: M. Tornblom et al., Variation in percentage-free prostate-specific antigen (PSA) with prostatevolume. age and total PSA level (vol 87, pg 638, 2001), BJU INT, 88(4), 2001, pp. 447-447
Authors:
Tornblom, M
Norming, U
Becker, C
Lilja, H
Gustafsson, O
Citation: M. Tornblom et al., Variation in percentage-free prostate-specific antigen (PSA) with prostatevolume, age and total PSA level, BJU INT, 87(7), 2001, pp. 638-642
Authors:
Becker, C
Noldus, J
Diamandis, E
Lilja, H
Citation: C. Becker et al., The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease, CR R CL LAB, 38(5), 2001, pp. 357-399
Authors:
Ylikoski, A
Karp, M
Lilja, H
Lovgren, T
Citation: A. Ylikoski et al., Dual-label detection of amplified products in quantitative RT-PCR assay using lanthanide-labeled probes, BIOTECHNIQU, 30(4), 2001, pp. 832
Authors:
Strandberg, K
Kjellberg, M
Knebel, R
Lilja, H
Stenflo, J
Citation: K. Strandberg et al., A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma: Use of a catcher antibody specific for the complexed/cleaved form of the inhibitor, THROMB HAEM, 86(2), 2001, pp. 604-610
Authors:
Hugosson, J
Lilja, H
Lodding, P
Pihl, CG
Citation: J. Hugosson et al., Tumor volume is a valid surrogate endpoint for defining clinically significant prostate cancers, EUR UROL, 39, 2001, pp. 33-34
Role of hK2. free PSA, and complexed PSA measurements in the very early detection of prostate cancer
Authors:
Lilja, H
Citation: H. Lilja, Role of hK2. free PSA, and complexed PSA measurements in the very early detection of prostate cancer, EUR UROL, 39, 2001, pp. 47-48
Authors:
Haese, A
Graefen, M
Steuber, T
Becker, C
Pettersson, K
Piironen, T
Noldus, J
Huland, H
Lilja, H
Citation: A. Haese et al., Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml, PROSTATE, 49(2), 2001, pp. 101-109
Authors:
Denmeade, SR
Lovgren, J
Khan, SR
Lilja, H
Isaacs, JT
Citation: Sr. Denmeade et al., Activation of latent protease function of Pro-HK2, but not Pro-PSA, involves autoprocessing, PROSTATE, 48(2), 2001, pp. 122-126
Authors:
Bjork, T
Schalken, J
Wittjes, W
Ljungberg, B
Lilja, H
Citation: T. Bjork et al., Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, andhuman glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues, PROSTATE, 47(1), 2001, pp. 14-20
Authors:
Amer-Wahlin, I
Hellsten, C
Noren, H
Hagberg, H
Herbst, A
Kjellmer, I
Lilja, H
Lindoff, C
Mansson, M
Martensson, L
Olofsson, P
Sundstrom, AK
Marsal, K
Citation: I. Amer-wahlin et al., Cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram for intrapartum fetal monitoring: a Swedish randomised controlled trial, LANCET, 358(9281), 2001, pp. 534-538
Authors:
Nurmikko, P
Pettersson, K
Piironen, T
Hugosson, J
Lilja, H
Citation: P. Nurmikko et al., Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys(145)-Lys(146), CLIN CHEM, 47(8), 2001, pp. 1415-1423
Authors:
Piironen, T
Nurmi, M
Irjala, K
Heinonen, O
Lilja, H
Lovgren, T
Pettersson, K
Citation: T. Piironen et al., Measurement of circulating forms of prostate-specific antigen in whole blood immediately after venipuncture: Implications for point-of-care testing, CLIN CHEM, 47(4), 2001, pp. 703-711
Authors:
Hamalainen, S
Lilja, H
Ojanpera, T
Citation: S. Hamalainen et al., Hierarchical cell structures, ART H UNI P, 2001, pp. 289-300
Authors:
Ellis, J
Wennerholm, UB
Bengtsson, A
Lilja, H
Pettersson, A
Sultan, B
Wennergren, M
Hagberg, H
Citation: J. Ellis et al., Levels of dimethylarginines and cytokines in mild and severe preeclampsia, ACT OBST SC, 80(7), 2001, pp. 602-608
Authors:
Nurmi, J
Lilja, H
Ylikoski, A
Citation: J. Nurmi et al., Time-resolved fluorometry in end-point and real-time PCR quantification ofnucleic acids, LUMINESCENC, 15(6), 2000, pp. 381-388
Authors:
Vaisanen, V
Harma, H
Lilja, H
Bjartell, A
Citation: V. Vaisanen et al., Time-resolved fluorescence imaging for quantitative histochemistry using lanthanide chelates in nanoparticles and conjugated to monoclonal antibodies, LUMINESCENC, 15(6), 2000, pp. 389-397
Authors:
Hugosson, J
Aus, G
Becker, C
Carlsson, S
Eriksson, H
Lilja, H
Lodding, P
Tibblin, G
Citation: J. Hugosson et al., Would prostate cancer detected by screening with prostate-specific antigendevelop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden, BJU INT, 85(9), 2000, pp. 1078-1084
Authors:
Malm, J
Hellman, J
Hogg, P
Lilja, H
Citation: J. Malm et al., Enzymatic action of prostate-specific antigen (PSA or hK3): Substrate specificity and regulation by Zn2+, a tight-binding inhibitor, PROSTATE, 45(2), 2000, pp. 132-139
Authors:
Siivola, P
Pettersson, K
Piironen, T
Lovgren, T
Lilja, H
Bjartell, A
Citation: P. Siivola et al., Time-resolved fluorescence imaging for specific and quantitative immunodetection of human kallikrein 2 and prostate-specific antigen in prostatic tissue sections, UROLOGY, 56(4), 2000, pp. 682-688
Authors:
Becker, C
Piironen, T
Pettersson, K
Hugosson, J
Lilja, H
Citation: C. Becker et al., Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater, UROLOGY, 55(5), 2000, pp. 694-699
Authors:
Haese, A
Becker, C
Noldus, J
Graefen, M
Huland, E
Huland, H
Lilja, H
Citation: A. Haese et al., Human glandular kallikrein 2: A potential serum marker for predicting the organ confined versus nonorgan confined growth of prostate cancer, J UROL, 163(5), 2000, pp. 1491-1497
Authors:
Becker, C
Piironen, T
Pettersson, K
Bjork, T
Wojno, KJ
Oesterling, JE
Lilja, H
Citation: C. Becker et al., Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (hK2) in serum, J UROL, 163(1), 2000, pp. 311-316
Authors:
Malm, J
Sorensen, O
Persson, T
Frohm-Nilsson, M
Johansson, B
Bjartell, A
Lilja, H
Stahle-Backdahl, M
Borregaard, N
Egesten, A
Citation: J. Malm et al., The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa, INFEC IMMUN, 68(7), 2000, pp. 4297-4302